Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

DB:I54 Stock Report

Market Cap: €321.7m

Biocytogen Pharmaceuticals (Beijing) Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:I54 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Sep 24Buy€476,895Veken Holding Group CO., LTD.Company700,000€0.68

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of I54?
Owner TypeNumber of SharesOwnership Percentage
Private Companies52,251,98013.1%
Employee Share Scheme54,695,16013.7%
Individual Insiders55,399,68013.9%
General Public55,450,68013.9%
VC/PE Firms75,921,48019%
Institutions105,679,44026.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 12 shareholders own 86.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.3%
UBS SDIC Fund Management Co., Ltd.
72,937,440€58.8m0%1.45%
13.7%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd, ESOP
54,695,160€44.1m0%no data
8.04%
CMB International Capital Management (Shenzhen) Co, Ltd.
32,110,920€25.9m0%1.92%
7.26%
Jian Ni
29,004,840€23.4m0%no data
6.61%
Yuelei Shen
26,394,840€21.3m0%no data
6.53%
Astral Eminent Limited
26,088,480€21.0m0%no data
5.89%
China Life Insurance (Group) Company Limited, Asset Management Arm
23,519,160€18.9m0%30.54%
5.89%
China Life Private Equity Investment Co., Ltd.
23,519,160€18.9m0%1.63%
5.08%
BVCF Management Ltd
20,291,400€16.3m0%39.39%
4.77%
Shenzhen Zhaoyin Chengzhang Shijiuhao Equity Investment Fund Partnership
19,060,920€15.4m0%no data
2.31%
New China Life Insurance Co., Ltd., Asset Management Arm
9,222,840€7.4m0%0.4%
1.78%
Veken Holding Group CO., LTD.
7,102,580€5.7m56.8%no data